Signant Health at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Signant Health takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on the quality of clinical rating data in Alzheimer's trials. Its work covers MMSE variability between screening and baseline across 17 trials and rating errors on hallucination and delusion items in psychosis trials.

OrganizationCTAD 2026 Attendance
Signant Health
Blue Bell, Pennsylvania
◇Silver Sponsor
signanthealth.com
CROs & trial servicesSilver Sponsor
eCOA and clinical-outcome-assessment provider that trains and monitors raters and reviews scale data quality in Alzheimer's trials.
Poster
Thu Nov 19
7:15am–5:00pm
Poster
Thu Nov 19
7:15am–5:00pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Signant Health

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction